Lupus (SLE): nyitott vizsgálatok itt: Izrael

10 nyitott vizsgálatnak van helyszíne itt: Izrael. Regiszteradat; hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

NCT07332481
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
Chaim Sheba Medical Center - pt, Ramat Gan
Regiszter frissítve: 2026-11-04
NCT07355218
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Kísérleti kezelés · 3. fázis · EMD Serono Research & Development Institute, Inc.
Tel Aviv Sourasky Medical Center-Derma - 150314762, Tel Aviv · Tel Aviv Sourasky Medical Center - Neurosurgery, Tel Aviv
Regiszter frissítve: 2026-11-04
NCT07438496
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Kísérleti kezelés · 3. fázis · Janssen Research & Development, LLC
Bnai Zion Medical Center, Haifa · Carmel Medical Center, Haifa · Rambam Health Care Campus, Haifa · Hadassah Ein-Qarem Medical Center, Jerusalem · Meir Medical Center, Kfar Saba · Galilee Medical Center, Nahariya · Tel-Aviv Sourasky Medical Center, Tel Aviv
Regiszter frissítve: 2026-11-03
NCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Kutatás · Bristol-Myers Squibb
Rambam Medical Center, Haifa · Carmel Medical Center, Haifa · Meir Medical Center, Kfar Saba · Rabin Medical Center - Hasharon hospital, Petah Tikva · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Regiszter frissítve: 2026-11-02
NCT07630714
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
Kísérleti kezelés · 2. fázis · AstraZeneca
Haifa · Kfar Saba · Petah Tikva · Ramat Gan · Tel Aviv
Regiszter frissítve: 2026-10-28
NCT07691970
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Kísérleti kezelés · 3. fázis · AstraZeneca
Haifa · Kfar Saba
Regiszter frissítve: 2026-10-28
NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Kísérleti kezelés · 3. fázis · Novartis Pharmaceuticals
Haifa · Ramat Gan
Regiszter frissítve: 2026-10-13
NCT05352919
A Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
Kísérleti kezelés · 3. fázis · Biogen
Rambam Health Care Campus, Haifa · Meir Medical Center, Kfar Saba · Chaim Sheba Medical Center, Ramat Gan · Tel Aviv Sourasky Medical Center Pt, Tel Aviv
Regiszter frissítve: 2026-10-05
NCT07115745
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Kísérleti kezelés · 1. fázis · Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Hadassah medical Center, Jerusalem · Sheba medical center, Ramat Gan
Regiszter frissítve: 2026-07-14
NCT07085676
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Kísérleti kezelés · 1. fázis · Polina Stepensky
Hadassah MO, Jerusalem
Regiszter frissítve: 2026-05-06

Minden vizsgálat (Lupus (SLE)) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek